Fig. 5From: Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trialsThe pooled risk ratio (RR) of patients with migraine 1 day after dosing in different treatment doses compared with placebo, the diamond indicates the estimated RR with 95% confidence interval (CI) for the pooled patientsBack to article page